Alkem Laboratories Limited (ALKEM) Share Price
NSE · Healthcare · Drug Manufacturers - Specialty & Generic · ISIN INE540L01014
Key metrics
- Market Cap
- ₹64,565 Cr
- P/E Ratio
- 29.94
- EPS
- 180.36
- Book Value
- 1,200.09
- P/B Ratio
- 4.5
- ROE
- 16.04%
- ROCE
- 16.16%
- Debt / Equity
- 0.14
- Net Margin
- 15.84%
- Revenue Growth
- 13.49%
- Profit Growth
- 6.3%
- Dividend Yield
- 0.37%
- 52W High
- ₹5,933.50
- 52W Low
- ₹5,075.00
- Market Cap Band
- large cap
- Face Value
- 2
Ratios computed from the annual results period ending 2026-03-31.
About Alkem Laboratories Limited
Alkem Laboratories Limited, a pharmaceutical company, engages in the research and development, manufacture, and sale of pharmaceutical and nutraceutical products in India, the United States, and internationally. The company offers biosimilars, active pharmaceutical ingredients, branded and trade generics, complex generics, and consumer wellness products in therapeutic areas comprising anti infective, anti-osteoporosis, cardiology, neurology, dermatology, diabetology, gastroenterology, gynecology, oncology, ophthalmology, respiratory, rheumatology, central nervous system, anti-diabetic, iron deficiency, pain management, and urology, as well as vitamins, minerals, and nutrients. It also provides cough syrups, hepatoprotective tonic, anti-dandruff shampoo, mouth wash, pregnancy detection kits, and condoms; and anti-bloating syrups, tablets, and powder. Alkem Laboratories Limited was incorporated in 1973 and is based in Mumbai, India.
- Headquarters
- Mumbai, India
- Employees
- 19,346
- Promoter Holding
- 62.44%
The full Alkem Laboratories Limited analysis
Create a free account to open the complete ALKEM deep-dive — fourteen tabs of fundamental, technical, institutional and ownership data.
- 10-year financialsIncome statement, balance sheet and cash flow, year by year.
- Valuation & fair valueFair-value estimates, quality scores and a value grade.
- Charts & technicalsCandlestick charts, RSI, MACD, Supertrend and detected patterns.
- Shareholding historyPromoter, FII, DII and public holdings across every quarter.
- Ace investor holdingsWhich well-known investors hold it, and how their stake changed.
- Deals & insider tradesBulk and block deals, insider transactions and mutual-fund holdings.